Search results
Sanofi strikes $1bn deal with Fulcrum for muscular dystrophy drug
Pharmaceutical Technology via Yahoo Finance· 2 days agoFulcrum Therapeutics has signed a $1bn exclusive licence deal with Sanofi to develop and...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 6 days agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
...Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases Doubts About Its...
Benzinga· 6 days agoFriday, Novavax Inc (NASDAQ: NVAX) entered a co-exclusive licensing agreement with Sanofi SA SNY for...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 5 days agoThe French drug giant Sanofi is taking a minority stake in Novavax and entering into a licensing...
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 6 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 2 days agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022....
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Investor's Business Daily· 5 days agoNovavax shares shot more than 125% higher Friday on news of a Covid-19 vaccine licensing agreement...
After FTC stalled Sanofi deal, Shionogi secures Maze's Pompe disease drug for $150M
FierceBiotech· 6 days agoIt appears Sanofi’s loss is Shionogi’s gain. Five months after the Federal Trade Commission (FTC) scuttled Sanofi’s attempt to acquire Maze Therapeutics ...
Novavax stock soars 120% as Sanofi deal 'kicks off a new chapter' By Investing.com
Investing.com· 6 days agoNovavax (NASDAQ:NVAX) shares skyrocketed more than 120% in premarket trading Friday, driven by the...
Private Advisor Group LLC Purchases 5,061 Shares of Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 4 days agoPrivate Advisor Group LLC raised its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 12.0% during the fourth quarter, according to its most recent disclosure with ...